Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current Smokers

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

July 28, 2025

Study Completion Date

October 6, 2025

Conditions

Nicotine

Interventions

OTHER

VM16

VM16 contains a liquid with a nicotine concentration of 1.6%

OTHER

VM32

VM32 contains a liquid with a nicotine concentration of 3.2%

OTHER

Cigarette (CC)

Subjects will provide their own usual brand of commercially available cigarettes

Trial Locations (1)

Celerion, Belfast

All Listed Sponsors

lead

Philip Morris Products S.A.

INDUSTRY